// App-Quantinova.ai

TCT-66 : Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES

Researchers

Presenter

  • Michela Faggioni

Principal Investigators

  • Serdar Farhan

  • Usman Baber

  • Mitchell Krucoff

  • Gennaro Giustino

  • Alaide Chieffo

  • Antonio Colombo

  • Timothy Henry

  • David Cohen

  • Giora Weisz

  • George Dangas

  • Charles Gibson

Medical Centers

  • Cedars-Sinai Heart Institute, Los Angeles, United States

  • AP-HP Groupe hospitalier Bichat- Claude Bernard, Paris, France

  • Shaare Zedek Medical Center, Jerusalem, Israel

  • CUMC, New York, New York, United States

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Saint Lukes Mid America Heart Institute, Kansas City, MO

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina, United States

  • Helios Amper-Klinikum Dachau, Berlin, Germany

  • San Raffaele Scientific Institute, Milan, Italy

  • Gibson Law Office, Dermott, United States

  • Montefiore Medical Center, Medicine, New York, United States

  • Cardiovascular Research Foundation, Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine, New York, New York, United States

Locations

  • Italy

  • Germany

  • United Kingdom

  • United States

  • Israel

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved